{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:13:59Z","timestamp":1760548439359,"version":"3.40.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/ncpendmet0506","type":"journal-article","created":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T14:14:01Z","timestamp":1177337641000},"page":"E1-E1","source":"Crossref","is-referenced-by-count":3,"title":["Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?"],"prefix":"10.1038","volume":"3","author":[{"given":"Steve V","family":"Edelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orville G","family":"Kolterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpendmet0506_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ncpendmet0454","volume":"3","author":"L Monnier","year":"2007","unstructured":"Monnier L (2007) Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes? Nat Clin Pract Endocrinol Metab 3: 332\u2013333","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"BFncpendmet0506_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1089\/dia.2006.8.644","volume":"8","author":"AL McCall","year":"2006","unstructured":"McCall AL  et al. (2006) A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther 8: 644\u2013653","journal-title":"Diabetes Technol Ther"},{"key":"BFncpendmet0506_CR3","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.2337\/diacare.26.11.3074","volume":"26","author":"C Weyer","year":"2003","unstructured":"Weyer C  et al. (2003) Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study. Diabetes Care 26: 3074\u20133079","journal-title":"Diabetes Care"},{"key":"BFncpendmet0506_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1463-1326.2004.00417.x","volume":"7","author":"SA Amiel","year":"2005","unstructured":"Amiel SA  et al. (2005) The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes. Diabetes Obes Metab 7: 504\u2013516","journal-title":"Diabetes Obes Metab"},{"key":"BFncpendmet0506_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.metabol.2004.04.010","volume":"53","author":"T Heise","year":"2004","unstructured":"Heise T  et al. (2004) Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects. Metabolism 53: 1227\u20131232","journal-title":"Metabolism"},{"key":"BFncpendmet0506_CR6","first-page":"1083","volume":"81","author":"B Nyholm","year":"1996","unstructured":"Nyholm B  et al. (1996) Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 1083\u20131089","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"BFncpendmet0506_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0026-0495(99)90232-9","volume":"48","author":"Birgit Nyholm","year":"1999","unstructured":"Nyholm B  et al. (1999) The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism 48: 935\u2013941","journal-title":"Metabolism"},{"key":"BFncpendmet0506_CR8","doi-asserted-by":"crossref","unstructured":"Karl D  et al. (2007) Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions and weight. Diabetes Technol Ther [10.1089\/dia.2006.0013]","DOI":"10.1089\/dia.2006.0013"},{"key":"BFncpendmet0506_CR9","unstructured":"SYMLIN\u00ae prescribing information: Amylin Pharmaceuticals [http:\/\/symlin.com\/pdf\/SYMLIN-pi-combined.pdf] (accessed 27 March 2007)"},{"key":"BFncpendmet0506_CR10","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group (1997) Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46: 271\u2013286","DOI":"10.2337\/diabetes.46.2.271"},{"key":"BFncpendmet0506_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2337\/dc06-1026","volume":"30","author":"DG Marrero","year":"2007","unstructured":"Marrero DG  et al. (2007) Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes. Diabetes Care 30: 210\u2013216","journal-title":"Diabetes Care"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0506","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T10:37:50Z","timestamp":1744281470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BFncpendmet0506"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0506","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"type":"print","value":"1745-8366"},{"type":"electronic","value":"1745-8374"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}